Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.56 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2184498 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A | |
| SCHEMBL3455495 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A | |
| SCHEMBL2137537 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A | |
| SCHEMBL3128648 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A | |
| SCHEMBL9235251 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A | |
| SCHEMBL2137541 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A | |
| SCHEMBL3625233 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A | |
| SCHEMBL2184557 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A | |
| SCHEMBL3625235 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A | |
| SCHEMBL3623659 | 1.00 | FAAH (0.58) | FAAHTRPV1CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024129979-A1 | METHOTREXATE TREATMENT METHODS | ALDEYRA THERAPEUTICS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| US-20240197740-A1 | METHOTREXATE TREATMENT METHODS | ALDEYRA THERAPEUTICS, INC. | 2024-06-20 | — | — | US | disclosed |
| US-11911385-B1 | Methotrexate treatment methods | ALDEYRA THERAPEUTICS, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| WO-2022204461-A1 | KITS, COMPOSITIONS, AND METHODS OF TREATING HAIR LOSS | ANDREWS NICK (US) | 2022-09-29 | — | — | WO | disclosed |
| US-20220133697-A1 | INJECTABLE FORMULATIONS | ALDEYRA THERAPEUTICS, INC. | 2022-05-05 | — | — | US | disclosed |
| EP-3890732-A1 | INJECTABLE FORMULATIONS | Aldeyra Therapeutics, Inc. (US) | 2021-10-13 | — | — | EP | disclosed |
| WO-2020118045-A1 | INJECTABLE FORMULATIONS | ALDEYRA THERAPEUTICS, INC. (US) | 2020-06-11 | — | — | WO | disclosed |
| US-10272040-B2 | Liposomal formulation for ocular drug delivery | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2019-04-30 | — | — | US | disclosed |
| US-20130216606-A1 | LIPOSOMAL FORMULATION FOR OCULAR DRUG DELIVERY | SINGAPORE HEALTH SERVICES PTE LTD (SG) | 2013-08-22 | — | — | US | disclosed |
| WO-2012021107-A2 | A LIPOSOMAL FORMULATION FOR OCULAR DRUG DELIVERY | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2012-02-16 | — | — | WO | disclosed |
| US-7789934-B2 | Combination of an N-alkyl- or N,N-dialkylpolyhydroxyalkanamide and a metal soap, an alkylenebisfatty amide, or an N-alkylalkanamide; improves both flowability and lubricity, regardless of a presence or absence of a complicated pretreatment step. | KABUSHIKI KAISHA KOBE SEIKO SHO (JP) | 2010-09-07 | — | — | US | disclosed |
| US-20070154340-A1 | Lubricant for powder metallurgy, powdery mixture for powder metallurgy, and process for producing sinter | KABUSHIKI KAISHA KOBE SEIKO SHO (JP) | 2007-07-05 | — | — | US | disclosed |
| US-4256903-A | REACTING SULFUR DIOXIDE AND CONJUGATED DIENES IN THE PRESENCE OF A MONO OR DI-ALKENYL AMINE | PHILLIPS PETROLEUM COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| US-3984478-A | TREATING AN UNSATURATED COMPOUND WITH CARBON MONOXIDE IN A HETEROGENEOUS CATALYST | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10272040-B2 | Liposomal formulation for ocular drug delivery | PTGS2, PTGES2, PTGER2 | FAAH 153/4885TRPV1 710/4885CYP1A2 465/4885 |
| US-20220133697-A1 | INJECTABLE FORMULATIONS | ALDH2, CLN6, ALDH1A1 | FAAH 874/4885TRPV1 2134/4885CYP1A2 298/4885 |
| US-20130216606-A1 | LIPOSOMAL FORMULATION FOR OCULAR DRUG DELIVERY | PTGS2, PTGES2, PTGER2 | FAAH 153/4885TRPV1 710/4885CYP1A2 465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.